Drug Development
Providers using this tag (142)
Ranked by API Evangelist rating — Exemplar and Strong are expanded by default.
Thin 2 Limited public surface area
Emerging 19 Early or largely undocumented
Champions OncologyEnjamb LabsAlloplex BiotherapeuticsEndeavor BioMedicinesEngrail TherapeuticsAbcuroADARx PharmaceuticalsBioAegis TherapeuticsArbor BiotechnologiesVeradermicsQUIBIMNacuity PharmaceuticalsTilda ResearchZetagen TherapeuticsAlzheonBluejay TherapeuticsActym TherapeuticsVedanta BiosciencesLEAF4Life
Minimal 118 Almost no public developer surface
Covance (Fortrea)Inovia BioCambrian BioOrchestraNovotechacxelnovamabCardurion PharmaAttralusAusperBioKirilys TherapeuticsQurAlisAbogen BiosciencesAlectorAlpha-9 OncologyApollomicsCardurion PharmaceuticalsDren BioFrontage LaboratoriesImbria PharmaceuticalsSidewinder TherapeuticsTigermedUpstream BioBiosplice TherapeuticsAdlai NortyeAngitia BiopharmaceuticalsTransposon TherapeuticsArriVentAardvark TherapeuticsZag BioantengeneBasking BiosciencesBitterroot BioCorsair PharmaCour Pharmaceuticals DevelopmentCreyon BioLENZ TherapeuticsRevalia BioRoivantSpero TherapeuticsTriveni BioEvommuneLatus BioRivus PharmaceuticalsOllin BioSionna TherapeuticsAngiexAverna TherapeuticsPathosAgomab TherapeuticsCG OncologyAutobahn TherapeuticsComanche BiopharmaLB PharmaceuticalsPharmaronPheon TherapeuticsFormation BioPhaseVOrsoBioAshvattha TherapeuticsBraveheart BioCarrick TherapeuticsCelerion (H.I.G. Capital)SpyBiotechConvokeSynthekine35PharmaPulmocideAlumisCandid TherapeuticsAcesion PharmaAvistoneArrivo BioVenturesBiorchestraCatalYmAsymchemReven PharmaceuticalsClarametyx BiosciencesRed RidgeBioDenali TherapeuticsImmune-Onc TherapeuticsAnsun BiopharmaArk BiopharmaceuticalBeiGenecnDizal PharmaShasqiDvlp MedicinesAiolos BioArthrosi TherapeuticsaceatherapeuticsAllena PharmaceuticalsImmunos TherapeuticskechowpharmaMetsera *Nocion TherapeuticsPerceive BioMendraPharmazzAbdera TherapeuticsBambusa TherapeuticsBoyuan PharmElion TherapeuticsChangsenpharmaceuticalCkregeonimmune-pathKelun-BiotechMinghui PharmaceuticalMycoMedicaNextcurePeninsula PharmaceuticalsCapacity BioConcentric AnalgesicsCell PathwaysDurata TherapeuticsEQRxFaraday PharmaceuticalsIterum Therapeutics
Unrated 3 Not yet scored
APIs with this tag (0)
No API pages are linked for this tag yet. Search apis.io →
Score breakdown
Frequency
58.5
log-scaled weighted occurrences
Breadth
3.3
spread across providers
Quality lift
8.7
mean composite of providers using it
Cohesion
0.0
strength of nearest seed neighbor
Where this tag sits
142 providers carry this tag directly, and 705 counting the 2 narrower tags below and the 2 beneath them — 563 more to reach.
Related tags
Biopharmaceutical 35 co-occurrences
Pharmaceuticals 96 co-occurrences
Clinical Trials 59 co-occurrences
Biotechnology 114 co-occurrences
Immunology 21 co-occurrences
Life Sciences 107 co-occurrences
Oncology 34 co-occurrences
Clinical Stage 14 co-occurrences
Where this tag comes from
Provider tag142
Cohort brief
Auto-generatedThe 117 providers in the APIs.io catalog tagged Drug Development, scored on the Kin Score. Every figure below is computed from the catalog — nothing here is written.
Providers
117
of 142 in the catalog
Mean Kin Score
even vs catalog
Mean Agent Readiness
2.1
-9.9 vs catalog 12
Spread
–
median · σ
How the 117 split by band
Exemplar 0Strong 0Developing 0Thin 2Emerging 21Minimal 94
Facet averages, against the whole catalog
| Facet | This cohort | Catalog | Difference | Scored |
|---|---|---|---|---|
| Contract Governance | 1.4 | 6.5 | -5.1 | 117 |
| Discoverability | 50.8 | 57.9 | -7.1 | 117 |
| Access Clarity | 12 | 23.9 | -11.9 | 117 |
| Operational Transparency | 0.4 | 13 | -12.6 | 117 |
| Contract Quality | 0.9 | 17.2 | -16.3 | 117 |
| Developer Ergonomics | 6.5 | 23.2 | -16.7 | 117 |
A facet is averaged over the members that carry it, not over the whole cohort — the “Scored” column is that count. Averaging an absent facet as zero would score our own coverage gaps as the providers’ posture.
What this cohort publishes
| Artifact | This cohort | Catalog | Difference |
|---|---|---|---|
| MCP server (any) | 7% | 13% | -6 |
| MCP server (first-party) | 3% | 12% | -9 |
| Agent Skills | 0% | 0% | 0 |
| OAuth scopes | 3% | 11% | -8 |
| Security | 98% | 98% | 0 |
| Arazzo workflows | 0% | 2% | -2 |
| Governance rules | 1% | 16% | -15 |
mcp_pct counts any mcp/ artifact including ones API Evangelist derived from the provider OpenAPI; mcp_first_party_pct counts only servers the provider publishes. Prefer the latter.
Top by Kin Score
Top by Agent Readiness
- 1 Orakl {"score" => 30.5, "band" => "agent-ready"}
- 2 Roivant Sciences {"score" => 26.9, "band" => "agent-aware"}
- 3 Endeavor BioMedicines {"score" => 20, "band" => "agent-aware"}
- 4 Veradermics {"score" => 19.1, "band" => "agent-aware"}
- 5 Engrail Therapeutics {"score" => 18.2, "band" => "agent-aware"}
- 6 Cardurion Pharma {"score" => 14.4, "band" => "agent-aware"}
- 7 Enjamb Labs {"score" => 12.2, "band" => "agent-aware"}
- 8 Convoke {"score" => 12.2, "band" => "agent-aware"}
- 9 Orchestra {"score" => 12.2, "band" => "agent-aware"}
- 10 Abcuro {"score" => 8.1, "band" => "agent-aware"}
All 142 members of this roster resolve to a provider in the
catalog; 117 carry a score (82%).
The figures above describe the scored members only.
Coverage caveat. 116 of 117 scored members had under half their catalog-attributable points satisfied at all (catalog_earned / catalog_max < 0.5). They are INCLUDED in the mean above. A large share here means the cohort mean is partly a measurement of how far our enrichment reached, not only of how these providers publish.Generated from the catalog build of 31 October 2026, across 31983 providers, using the same computation served by the APIs.io cohort API. Briefs are published for rosters of 5 or more scored providers; below that a distribution is not meaningful.
Coverage caveat. 116 of 117 scored members had under half their catalog-attributable points satisfied at all (catalog_earned / catalog_max < 0.5). They are INCLUDED in the mean above. A large share here means the cohort mean is partly a measurement of how far our enrichment reached, not only of how these providers publish.Generated from the catalog build of 31 October 2026, across 31983 providers, using the same computation served by the APIs.io cohort API. Briefs are published for rosters of 5 or more scored providers; below that a distribution is not meaningful.
Work with this as data
Every tag here is available over the APIs.io API and to AI agents over MCP.